Position Statements

Truth, Justice and Reconciliation
September 27, 2022

To the CAREB-ACCER and broader Research Ethics Community: There is a need for action, accountability, [...]

CAREB-ACCER’s comments in response to the CCTCC REB Accreditation Working Group Consultation
June 21, 2020

In May 2016, the REB Accreditation Working Group of the Canadian Clinical Trials Coordinating Centre (CCTCC) released its Draft [...]

CAREB-ACCER Response to Draft RDM Policy – 2018
October 9, 2018

File: CAREB-ACCER Response to Draft RDM Policy – 2018 [...]

CAREB-ACCER’s response to the U.S. Notice of Proposed Rulemaking (NPRM) – Federal Policy for the Protection of Human Subjects
February 10, 2016

In September, 2015, the U.S. Department of Health and Human Services (HHS) and fifteen other [...]

Human Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators
October 26, 2011

October 2011 – The CAREB Board of Directors recently filed comments to the Department of Health and Human [...]

Responsible Conduct of Research (RCR)
September 26, 2011

September 2011 – The CAREB Board of Directors filed comments in response to the Tri-Agency’s proposed framework on [...]

Reporting of Unanticipated Problems including Adverse Events to Research Ethics Boards in Canada
July 1, 2010

July 2010 – CAREB issued their first guidance document Reporting of Unanticipated Problems including Adverse Events to [...]